These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3151919)

  • 1. Structural studies leading to the discovery of a cannabinoid binding site.
    Johnson M; Devane W; Howlett A; Melvin L; Milne G
    NIDA Res Monogr; 1988; 90():129-35. PubMed ID: 3151919
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
    Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
    Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
    Melvin LS; Milne GM; Johnson MR; Subramaniam B; Wilken GH; Howlett AC
    Mol Pharmacol; 1993 Nov; 44(5):1008-15. PubMed ID: 8246904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.
    Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC
    Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology: planning for serendipity.
    Snyder SH
    Nature; 1990 Aug; 346(6284):508. PubMed ID: 2165565
    [No Abstract]   [Full Text] [Related]  

  • 6. A pyridone analogue of traditional cannabinoids. A new class of selective ligands for the CB(2) receptor.
    Huffman JW; Lu J; Hynd G; Wiley JL; Martin BR
    Bioorg Med Chem; 2001 Nov; 9(11):2863-70. PubMed ID: 11597467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids.
    Lynn AB; Herkenham M
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1612-23. PubMed ID: 8138973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional neuroanatomy of brain cannabinoid receptors.
    Breivogel CS; Childers SR
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):417-31. PubMed ID: 9974175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM; Compton DR; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical/nonclassical hybrid cannabinoids: southern aliphatic chain-functionalized C-6beta methyl, ethyl, and propyl analogues.
    Drake DJ; Jensen RS; Busch-Petersen J; Kawakami JK; Concepcion Fernandez-Garcia M; Fan P; Makriyannis A; Tius MA
    J Med Chem; 1998 Sep; 41(19):3596-608. PubMed ID: 9733485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of functionalized cannabinoids.
    Harrington PE; Stergiades IA; Erickson J; Makriyannis A; Tius MA
    J Org Chem; 2000 Oct; 65(20):6576-82. PubMed ID: 11052105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction.
    Chang MC; Berkery D; Schuel R; Laychock SG; Zimmerman AM; Zimmerman S; Schuel H
    Mol Reprod Dev; 1993 Dec; 36(4):507-16. PubMed ID: 8305215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of covalent probes for the radiolabeling of the cannabinoid receptor.
    Chu C; Ramamurthy A; Makriyannis A; Tius MA
    J Org Chem; 2003 Jan; 68(1):55-61. PubMed ID: 12515461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
    Compton DR; Rice KC; De Costa BR; Razdan RK; Melvin LS; Johnson MR; Martin BR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):218-26. PubMed ID: 8474008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
    Rhee MH; Vogel Z; Barg J; Bayewitch M; Levy R; Hanus L; Breuer A; Mechoulam R
    J Med Chem; 1997 Sep; 40(20):3228-33. PubMed ID: 9379442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain cannabinoid systems as targets for the therapy of neurological disorders.
    Consroe P
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):534-51. PubMed ID: 9974182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
    Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
    J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical and nonclassical cannabinoids: mechanism of action--brain binding.
    Howlett AC; Johnson MR; Melvin LS
    NIDA Res Monogr; 1990; 96():100-11. PubMed ID: 2172821
    [No Abstract]   [Full Text] [Related]  

  • 20. The CB1 cannabinoid receptor in the brain.
    Howlett AC
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):405-16. PubMed ID: 9974174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.